!!! New Study Publication!!!
"Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization"

Adding PleuraFlow’s Active Chest Tube Clearance (ATC) to an ERAS cardiac surgery program reduced Retained Blood Syndrome by 41%, postoperative atrial fibrillation (POAF) by 17%, and ICU time by 30% in 684 patients compared to 650 controls, improving outcomes and resource utilization. (Gerdisch, et al, 2025)

Blog

BlogArticle

PleuraFlow® wins international design and manufacturing awards

Building on our innovation award from the European Association of Cardiothoracic Surgeons award in 2009, the company received additions awards in 2010. PleuraFlow® was awarded an international industrial design distinction award from I.D. Magazine. In addition, PleuraFlow® was awarded a manufacturing excellence award as the top innovation of the year from Fenner, a $1B international manufacturing giant that bought our manufacturing partner, MRI, in 2010.